跳至主要内容
临床试验/ISRCTN42862937
ISRCTN42862937已完成未知

Protocol for a longitudinal, cohort study to evaluate Reactivation of Herpesviruses and Inflammation as Cardiovascular and Cerebrovascular risk factors in Antiretroviral initiators, in an African HIV population (RHICCA)

GlaxoSmithKline0 个研究点目标入组 1,090 人开始时间: 2018年5月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
1,090

研究概览

简要总结

2019 Protocol article in https://pubmed.ncbi.nlm.nih.gov/31515413/ protocol (added 05/10/2020)

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Aged => 35 years
  • 2. Resident in Blantyre
  • 3. HIV-infected patients must further be ART-naïve or initiated ART <10 days prior to enrolment
  • 4. Initiating standard first-line ART (in Malawi this is: TDF/3TC/EFV)
  • 5. Adult controls must further be HIV uninfected

排除标准

  • 1. Clinical history of CVD/CBD
  • 2. Pregnant
  • 3. Critically ill or have symptomatic anaemia at enrolment
  • 4. Enrolled in an intervention study

研究者

相似试验